FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jennifer Richer

Research Profile

Chemicals & Drugs

Disorders

Physiology

Anatomy

Procedures

Co-author Network

Publications

TOP 3
Diana M Cittelly; Dawn R Cochrane; Irina Dimitrova; Erin N Howe; Annie Jean; Xian Lu; Miriam D Post; Monique A Spillman; Nicole S Spoelstra; Russell R Broaddus; Jennifer K Richer
Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel.
Dawn R Cochrane; Nicole S Spoelstra; Jennifer K Richer
The role of miRNAs in progesterone action.
Dawn R Cochrane; Keith D Connaghan; Erin N Howe; Britta M Jacobsen; David L Bain; Jennifer K Richer
Progestin regulated miRNAs that mediate progesterone receptor action in breast cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jennifer Richer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Diana M Cittelly; Dawn R Cochrane; Irina Dimitrova; Erin N Howe; Annie Jean; Xian Lu; Miriam D Post; Monique A Spillman; Nicole S Spoelstra; Russell R Broaddus; Jennifer K Richer
Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel.
Molecular cancer therapeutics 2012;11(12):2556-65.
2012: Dawn R Cochrane; Nicole S Spoelstra; Jennifer K Richer
The role of miRNAs in progesterone action.
Molecular and cellular endocrinology 2012;357(1-2):50-9.
2012: Dawn R Cochrane; Keith D Connaghan; Erin N Howe; Britta M Jacobsen; David L Bain; Jennifer K Richer
Progestin regulated miRNAs that mediate progesterone receptor action in breast cancer.
Molecular and cellular endocrinology 2012;355(1):15-24.
2012: Erin N Howe; Dawn R Cochrane; Jennifer K Richer
The miR-200 and miR-221/222 microRNA families: opposing effects on epithelial identity.
Journal of mammary gland biology and neoplasia 2012;17(1):65-77.
2012: Erin N Howe; Diana M Cittelly; Dawn R Cochrane; Jennifer K Richer
miR-200c targets a NF-κB up-regulated TrkB/NTF3 autocrine signaling loop to enhance anoikis sensitivity in triple negative breast cancer.
PloS one 2012;7(11):e49987.
2011: Erin N Howe; Dawn R Cochrane; Jennifer K Richer
Targets of miR-200c mediate suppression of cell motility and anoikis resistance.
Breast cancer research : BCR 2011;13(2):R45.
2011: Dawn R Cochrane; Diana M Cittelly; Jennifer K Richer
Steroid receptors and microRNAs: relationships revealed.
Steroids 2011;76(1-2):1-10.
2010: Diana M Cittelly; partha das; Nicole S Spoelstra; Susan M Edgerton; Jennifer K Richer; Ann D Thor; Frank E Jones
Downregulation of miR-342 is associated with tamoxifen resistant breast tumors.
Molecular cancer 2010;9():317.
2010: Diana M Cittelly; Jennifer K Richer; Carol A Sartorius
Ovarian steroid hormones: what's hot in the stem cell pool?
Breast cancer research : BCR 2010;12(4):309.
2010: Dawn R Cochrane; Erin N Howe; Nicole S Spoelstra; Jennifer K Richer
Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers.
Journal of oncology 2010;2010():821717.
2009: Irina K Dimitrova; Jennifer K Richer; Michael C Rudolph; Nicole S Spoelstra; Elaine M Reno; Theresa M Medina; Andrew P Bradford
Gene expression profiling of multiple leiomyomata uteri and matched normal tissue from a single patient.
Fertility and sterility 2009;91(6):2650-63.
2009: Dawn R Cochrane; Nicole S Spoelstra; Erin N Howe; Steven K Nordeen; Jennifer K Richer
MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents.
Molecular cancer therapeutics 2009;8(5):1055-66.
2008: Djuana M E Harvell; Jennifer K Richer; Meenakshi Singh; Nicole S Spoelstra; Christina Finlayson; Virginia F Borges; Anthony D Elias; Kathryn B Horwitz
Estrogen regulated gene expression in response to neoadjuvant endocrine therapy of breast cancers: tamoxifen agonist effects dominate in the presence of an aromatase inhibitor.
Breast cancer research and treatment 2008;112(3):489-501.
2008: Djuana M E Harvell; Nicole S Spoelstra; Meenakshi Singh; James L McManaman; Christina Finlayson; Tzu Phang; Susan Trapp; Lawrence Hunter; Wendy W Dye; Virginia F Borges; Anthony Elias; Kathryn B Horwitz; Jennifer K Richer
Molecular signatures of neoadjuvant endocrine therapy for breast cancer: characteristics of response or intrinsic resistance.
Breast cancer research and treatment 2008;112(3):475-88.
2008: Meenakshi Singh; Nicole S Spoelstra; Annie Jean; Erin Howe; Kathleen C Torkko; Hilda R Clark; Douglas Darling; Kenneth R Shroyer; Kathryn B Horwitz; Russell R Broaddus; Jennifer K Richer
ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(7):912-23.
2006: Nicole N Balmer; Jennifer K Richer; Nicole S Spoelstra; Kathleen C Torkko; Pamela L Lyle; Meenakshi Singh
Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: Correlation with clinicopathologic parameters and biomarkers.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19(12):1593-605.
2006: Lin Tung; Hany Abdel-Hafiz; Tianjie Shen; Djuana M E Harvell; Lisa K Nitao; Jennifer K Richer; Carol A Sartorius; Glenn S Takimoto; Kathryn B Horwitz
Progesterone receptors (PR)-B and -A regulate transcription by different mechanisms: AF-3 exerts regulatory control over coactivator binding to PR-B.
Molecular endocrinology (Baltimore, Md.) 2006;20(11):2656-70.
2006: Nicole S Spoelstra; Nicole G Manning; Yujiro Higashi; Douglas Darling; Meenakshi Singh; Kenneth R Shroyer; Russell R Broaddus; Kathryn B Horwitz; Jennifer K Richer
The transcription factor ZEB1 is aberrantly expressed in aggressive uterine cancers.
Cancer research 2006;66(7):3893-902.
2006: Djuana M E Harvell; Jennifer K Richer; D Craig Allred; Carol A Sartorius; Kathryn B Horwitz
Estradiol regulates different genes in human breast tumor xenografts compared with the identical cells in culture.
Endocrinology 2006;147(2):700-13.
2005: Jeffrey D Bray; Scott Jelinsky; Radhika Ghatge; Jenifer A Bray; Christopher Tunkey; Kathryn Saraf; Britta M Jacobsen; Jennifer K Richer; Eugene L Brown; Richard Winneker; Kathryn B Horwitz; C Richard Lyttle
Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells.
The Journal of steroid biochemistry and molecular biology 2005;97(4):328-41.
2005: Andrés Carvajal; Natalia Espinoza; Sumie Kato; Mauricio Pinto; Anil Sadarangani; Carolina Monso; E Aranda; Manuel Villalon; Jennifer K Richer; Kathryn B Horwitz; Jan J Brosens; Gareth Owen
Progesterone pre-treatment potentiates EGF pathway signaling in the breast cancer cell line ZR-75.
Breast cancer research and treatment 2005;94(2):171-83.
2005: Britta M Jacobsen; Stephanie A Schittone; Jennifer K Richer; Kathryn B Horwitz
Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology.
Molecular endocrinology (Baltimore, Md.) 2005;19(3):574-87.
2005: Sumie Kato; Mauricio Pinto; Andrés Carvajal; Natalia Espinoza; Carolina Monso; Anil Sadarangani; Manuel Villalon; Jan J Brosens; John O White; Jennifer K Richer; Kathryn B Horwitz; Gareth Owen
Progesterone increases tissue factor gene expression, procoagulant activity, and invasion in the breast cancer cell line ZR-75-1.
The Journal of clinical endocrinology and metabolism 2005;90(2):1181-8.
2004: Jianbo Wu; Jennifer K Richer; Kathryn B Horwitz; Salman M Hyder
Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B.
Cancer research 2004;64(6):2238-44.
2003: Britta M Jacobsen; Jennifer K Richer; Carol A Sartorius; Kathryn B Horwitz
Expression profiling of human breast cancers and gene regulation by progesterone receptors.
Journal of mammary gland biology and neoplasia 2003;8(3):257-68.
2003: Glenn S Takimoto; Lin Tung; Hany Abdel-Hafiz; M Greg Abel; Carol A Sartorius; Jennifer K Richer; Britta M Jacobsen; David L Bain; Kathryn B Horwitz
Functional properties of the N-terminal region of progesterone receptors and their mechanistic relationship to structure.
The Journal of steroid biochemistry and molecular biology 2003;85(2-5):209-19.
2002: Britta M Jacobsen; Jennifer K Richer; Stephanie A Schittone; Kathryn B Horwitz
New human breast cancer cells to study progesterone receptor isoform ratio effects and ligand-independent gene regulation.
The Journal of biological chemistry 2002;277(31):27793-800.
2002: Jennifer K Richer; Britta M Jacobsen; Nicole G Manning; M Greg Abel; Douglas M Wolf; Kathryn B Horwitz
Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells.
The Journal of biological chemistry 2002;277(7):5209-18.
2000: JD Graham; David L Bain; Jennifer K Richer; Twila A Jackson; Lin Tung; Kathryn B Horwitz
Thoughts on tamoxifen resistant breast cancer. Are coregulators the answer or just a red herring?
The Journal of steroid biochemistry and molecular biology 2000;74(5):255-9.
2000: JD Graham; David L Bain; Jennifer K Richer; Twila A Jackson; Lin Tung; Kathryn B Horwitz
Nuclear receptor conformation, coregulators, and tamoxifen-resistant breast cancer.
Steroids 2000;65(10-11):579-84.
2000: Carol A Sartorius; Glenn S Takimoto; Jennifer K Richer; Lin Tung; Kathryn B Horwitz
Association of the Ku autoantigen/DNA-dependent protein kinase holoenzyme and poly(ADP-ribose) polymerase with the DNA binding domain of progesterone receptors.
Journal of molecular endocrinology 2000;24(2):165-82.
1999: Carol A Lange; Jennifer K Richer; Kathryn B Horwitz
Hypothesis: Progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals.
Molecular endocrinology (Baltimore, Md.) 1999;13(6):829-36.
1999: Yvonne K Hodges; Jennifer K Richer; Kathryn B Horwitz; Lawrence D Horwitz
Variant estrogen and progesterone receptor messages in human vascular smooth muscle.
Circulation 1999;99(20):2688-93.
1998: Jennifer K Richer; Carol A Lange; Nicole G Manning; Gareth Owen; R Powell; Kathryn B Horwitz
Convergence of progesterone with growth factor and cytokine signaling in breast cancer. Progesterone receptors regulate signal transducers and activators of transcription expression and activity.
The Journal of biological chemistry 1998;273(47):31317-26.
1998: Carol A Lange; Jennifer K Richer; Tianjie Shen; Kathryn B Horwitz
Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways.
The Journal of biological chemistry 1998;273(47):31308-16.
1998: NS Kumar; Jennifer K Richer; Gareth Owen; Elizabeth S Litman; Kathryn B Horwitz; Kimberly K Leslie
Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action.
Cancer research 1998;58(9):1860-5.
1998: Gareth Owen; Jennifer K Richer; Lin Tung; Glenn S Takimoto; Kathryn B Horwitz
Progesterone regulates transcription of the p21(WAF1) cyclin- dependent kinase inhibitor gene through Sp1 and CBP/p300.
The Journal of biological chemistry 1998;273(17):10696-701.
1998: Jennifer K Richer; Carol A Lange; A M Wierman; K M Brooks; Lin Tung; Glenn S Takimoto; Kathryn B Horwitz
Progesterone receptor variants found in breast cells repress transcription by wild-type receptors.
Breast cancer research and treatment 1998;48(3):231-41.
1997: Kimberly K Leslie; NS Kumar; Jennifer K Richer; Gareth Owen; Glenn S Takimoto; Kathryn B Horwitz; Carol A Lange
Differential expression of the A and B isoforms of progesterone receptor in human endometrial cancer cells. Only progesterone receptor B is induced by estrogen and associated with strong transcriptional activation.
Annals of the New York Academy of Sciences 1997;828():17-26.
1997: M M Miller; R A James; Jennifer K Richer; David F Gordon; William M Wood; Kathryn B Horwitz
Progesterone regulated expression of flavin-containing monooxygenase 5 by the B-isoform of progesterone receptors: implications for tamoxifen carcinogenicity.
The Journal of clinical endocrinology and metabolism 1997;82(9):2956-61.
1997: Twila A Jackson; Jennifer K Richer; David L Bain; Glenn S Takimoto; Lin Tung; Kathryn B Horwitz
The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT.
Molecular endocrinology (Baltimore, Md.) 1997;11(6):693-705.
1996: Kathryn B Horwitz; Twila A Jackson; D L Bain; Jennifer K Richer; Glenn S Takimoto; Lin Tung
Nuclear receptor coactivators and corepressors.
Molecular endocrinology (Baltimore, Md.) 1996;10(10):1167-77.